InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,481.24
(
-0.74%
)
US TECH 100
18,643.80
(
-1.06%
)
Dow Jones
40,346.49
(
-1.22%
)
Brent Oil
80.39
(
-1.37%
)
Bitcoin
62,900.02
(
-2.61%
)
Post# of 252758
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120173
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 130426

Monday, 11/07/2011 11:16:30 AM

Monday, November 07, 2011 11:16:30 AM

Post# of 252758

They [SNY] gain little other than a foothold for the AG to use when other generics reach market.

SNY gained something else from the AG launch: a defense other than price-cutting to NVS’ market-share gains in the hospital segment, which is for SNY to gain share in the retail segment. Without an AG, SNY couldn’t have done that.

I think we’re on the same wavelength here.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up